SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001609251-24-000004
Filing Date
2024-02-27
Accepted
2024-02-27 13:11:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 31435
  Complete submission text file 0001609251-24-000004.txt   33086
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Subject) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SCHEDULE 13G | Act: 34 | File No.: 005-87373 | Film No.: 24684628
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 610 FIFTH AVENUE SUITE 301 NEW YORK NY 10020
Business Address 610 FIFTH AVENUE SUITE 301 NEW YORK NY 10020 212-888-1582
Krensavage Asset Management, LLC (Filed by) CIK: 0001609251 (see all company filings)

IRS No.: 262520930 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G